Sisk, J.E., and Glied, S.A. (1994). Innovation under federal health care reform. Health Affairs, 13(3), 82-97.
Sorensen, J.L., Hall, S.M., Loeb, P., Allen, T., Glaser, E.M., and Greenberg, P.D. (1988). Dissemination of a job seekers’ workshop to drug treatment programs. Behavior Therapy, 19, 143-155.
Spangler, J.G., Goerge, G., Foley, K.L., and Cradell, S.K. (2002). Tobacco intervention training: Current efforts and gaps in U.S. medical schools. Journal of the American Medical Association, 288(9), 1102-1109.
Stein, M.D., and Friedmann, P.D. (2001). Generalist physicians and addiction care: From turfing to sharing the turf. Journal of the American Medical Association, 286(14), 1764-1765.
Stone, T.T., Longo, D.R., Phillps, R.L., Hewett, E., and Riley, S.L. (2002). Health care system and insurer support for smoking cessation guideline implementation. Journal of Health Care Finance, 29(2), 78-86.
Strang, D., and Soule, S.A. (1998). Diffusion in organizations and social movements: From hybrid corn to poison pills. Annual Review of Sociology, 24, 265-290.
Substance Abuse and Mental Health Services Administration. (2002). National Survey of Substance Abuse Treatment Services (N-SSATS): 2000. Data on substance abuse treatment facilities. Rockville, MD: Author.
Teplensky, J.D., Pauly, M.V., Kimberly, J.R., Hillman, A.L., and Schwartz, J.S. (1995). Hospital adoption of medical technology: An empirical test of alternative models. Health Services Research, 30(3), 437-465.
Teplin, L.A., Abram, K.M., and Michaels, S.K. (1989). Blood alcohol level among emergency room patients: A multivariate analysis. Journal of Studies on Alcohol, 50(5), 441-447.
Thirion, X., Lapierre, V., Micallef, J., Ronfle, E., Masut, A., Pradel, V., Coudert, C., Mabriez, J.C., and Sanmarco, J.L. (2002). Buprenorphine presription by general practitioners in a French region. Drug and Alcohol Dependence, 65(2), 197-204.
Thomas, C.P. (2000). No magic bullet: Adoption of naltrexone by clinical providers. Dissertation, Brandeis University.
Thomas, C.P., Wallack, S., Lee, S.S., McCarty, D., and Swift, R. (2003). Research to practice: Factors affecting the adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment, 24(1), 1-11.
Tolbert, P.S., and Zucker, L.G. (1983). Institutional sources of change in the formal structure of organizations: The diffusion of civil service reform. Administrative Science Quarterly, 28, 22-39.
Turk, D.C., and Okifuji, A. (1997). What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients? The Clinical Journal of Pain, 13(4), 330-336.
U.S. Public Health Service. (2000). Treating tobacco use and dependence—A systems approach. A guide for health care administrators, insurers, managed care organizations, and purchasers. Available: http://www.surgeongeneral.gov/tobacco/systems.htm [December 24, 2003].
U.S. Veterans Administration. (1999a). Relative cost effectiveness of tobacco use cessation pharmacotherapies. Pharmacoeconomic Center Update, 8.
U.S. Veterans Administration. (1999b). Tobacco use cessation in the primary care setting. Pharmacoeconomic Center Update, 1.
Van den Bulte, C., and Lilien, G.L. (2001). Medical innovation revisited: Social contagion versus marketing effort. American Journal of Sociology, 106, 1409-1435.
Vaughan, T.E., Ward, M.M., Doebbing, B.N., Uden-Holman, T., Clarke, W.T., and Woolson, R.F. (2002). Organizational and provider characteristics fostering smoking cessation practice guideline adherence: An empirical look. Journal of Ambulatory Care Management, 25(2), 17-31.